3.0
Dec 5, 2023
Recommend
CEO approval
Business Outlook
Pros
Managers listen Patient focused Remote work
Cons
Assets investments not well thought out. Recent deals caused layoffs as they are way over R&D budget. Starting to feel like big pharma under former big pharma leadership. Decision making has become slow.